Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:00:12 EDT Mon 25 May 2026
Enter Symbol
or Name
USA
CA



Q:CAMP - CAMP4 THERAPEUTICS CORPORATION - https://www.calamp.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CAMP - Q0.13.73·6.510.14.51    7.75  1.305May 22May 2115 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-21 16:05U:CAMPNews ReleaseCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-05-14 07:00U:CAMPNews ReleaseCAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
2026-05-07 16:05U:CAMPNews ReleaseCAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
2026-04-28 08:00U:CAMPNews ReleaseCAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
2026-04-17 16:05U:CAMPNews ReleaseCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-03-24 07:00U:CAMPNews ReleaseCAMP4 Appoints Michael MacLean to its Board of Directors
2026-03-06 16:05U:CAMPNews ReleaseCAMP4 to Participate in Upcoming Investor Conferences
2026-03-05 16:05U:CAMPNews ReleaseCAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
2026-02-20 16:05U:CAMPNews ReleaseCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-01-16 16:05U:CAMPNews ReleaseCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-01-06 08:00U:CAMPNews ReleaseCAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-18 07:10U:CAMPNews ReleaseCAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
2025-12-18 07:00U:CAMPNews ReleaseCAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
2025-12-12 16:05U:CAMPNews ReleaseCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-11-14 16:05U:CAMPNews ReleaseCAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2025-11-06 16:05U:CAMPNews ReleaseCAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
2025-10-01 08:00U:CAMPNews ReleaseCAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
2025-09-10 07:00U:CAMPNews ReleaseCAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
2025-08-14 16:05U:CAMPNews ReleaseCAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights